BATS:HELX Franklin Genomic Advancements ETF (HELX) Price, Holdings, & News → Will this $2 AI stock double overnight? (From Behind the Markets) (Ad) Free HELX Stock Alerts $30.46 -0.19 (-0.62%) (As of 04/24/2024 ET) Add Compare Share Share Today's Range$30.46▼$30.4950-Day Range$29.32▼$32.9252-Week Range N/AVolume527 shsAverage VolumeN/AMarket Capitalization$9.14 millionAssets Under Management$9.20 millionDividend YieldN/ANet Expense Ratio0.50% Stock AnalysisStock AnalysisChartHoldingsRatingsStock AnalysisChartHoldingsRatings Get Franklin Genomic Advancements ETF alerts: Email Address About Franklin Genomic Advancements ETFThe Franklin Genomic Advancements ETF (HELX) is an exchange-traded fund that is based on the Solactive Genomics index. The fund is an actively managed portfolio of global equity securities of companies relevant to genomic discovery. HELX was launched on Feb 25, 2020 and is managed by Franklin Templeton.Read More HELX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HELX ETF News HeadlinesApril 23, 2024 | lse.co.ukFranklin Catholic Princ Em Sov Ucits Etf Share Price (CATHEM.MI)March 27, 2024 | money.usnews.comFranklin U.S. Treasury Bond ETFApril 25, 2024 | Behind the Markets (Ad)Will this $2 AI stock double overnight?It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!November 25, 2023 | lse.co.ukFranklin Msci China Paris Alig Ucits Etf Share Price (FRCP.MI)November 17, 2023 | lse.co.ukFranklin Emerging Markets Ucits Etf Share Price (FLXE.MI)February 25, 2023 | morningstar.comBMO ARK Genomic Revolution ETF SeriesSee More Headlines Receive HELX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Franklin Genomic Advancements ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerFranklin Templeton Investments Fund NameFranklin Genomic Advancements ETF Tax ClassificationRegulated Investment Company Stock ExchangeBATSCurrent SymbolBATS:HELX Inception Date2/25/2020 Fund ManagerMatthew J.Moberg, Joyce Lin WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings65 Fund Statistics Assets Under Management$9.20 million Average Daily Volume$0.00 Discount/Premium-0.01% Administrator, Advisor and Custodian AdministratorFranklin Templeton Services, LLC AdvisorFranklin Advisers, Inc. CustodianState Street Bank and Trust Company DistributorFranklin Templeton Distributors, Inc. Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerCitadel Miscellaneous Outstanding Shares300,000Beta0.96 Creation Unit50,000 Creation Fee$200.00 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Ad Behind the MarketsWill this $2 AI stock double overnight?It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!Click here to learn more >>> Franklin Genomic Advancements ETF ExpensesTypeHELXTheme ETFsEquity ETFsBATS ETFsAll ETFsManagement Fee0.50%0.57%0.54%0.56%0.51%Other Expenses0.00%0.72%0.54%0.51%0.58%Total Expense0.50%0.72%0.70%0.68%0.70%Fee Waiver0.00%-0.76%-0.55%-0.34%-0.57%Net Expense0.50%0.59%0.60%0.63%0.58% Franklin Genomic Advancements ETF (HELX) Holdings & ExposureTop 10 HELX HoldingsMedpace(NASDAQ:MEDP)Holding Weight: 7.58%Vertex Pharmaceuticals(NASDAQ:VRTX)Holding Weight: 4.80%Thermo Fisher Scientific(NYSE:TMO)Holding Weight: 4.78%Regeneron Pharmaceuticals(NASDAQ:REGN)Holding Weight: 4.63%Eli Lilly and Company(NYSE:LLY)Holding Weight: 4.38%Krystal Biotech(NASDAQ:KRYS)Holding Weight: 4.27%Danaher(NYSE:DHR)Holding Weight: 4.10%Samsung BioLogics Co LtdHolding Weight: 3.16%Bruker(NASDAQ:BRKR)Holding Weight: 3.15%Natera(NASDAQ:NTRA)Holding Weight: 2.94%HELX Sector ExposureHELX Industry ExposureFull Holdings Details Similar ETFsHorizon Kinetics Blockchain Development ETFNYSEARCA:BCDFAVDR US LargeCap ESG ETFBATS:AVDGAmplify Treatments, Testing and Advancements ETFNYSEARCA:GERMStrive FAANG 2.0 ETFNYSEARCA:FTWOIQ Healthy Hearts ETFNYSEARCA:HART HELX ETF - Frequently Asked Questions How have HELX shares performed in 2024? Franklin Genomic Advancements ETF's stock was trading at $30.47 at the start of the year. Since then, HELX stock has decreased by 0.0% and is now trading at $30.4609. View the best growth stocks for 2024 here. What does HELX invest in? Franklin Genomic Advancements ETF is a equity fund issued by Franklin Templeton Investments. HELX focuses on theme investments. The fund's investments total to approximately $9.20 million assets under management. What stocks does Franklin Genomic Advancements ETF hold? HELX invests in 65 holdings. Some of the stocks in their portfolio include Medpace (MEDP), Vertex Pharmaceuticals (VRTX), Thermo Fisher Scientific (TMO), Regeneron Pharmaceuticals (REGN), Eli Lilly and Company (LLY), Krystal Biotech (KRYS), Danaher (DHR), Bruker (BRKR), Natera (NTRA) and AstraZeneca (AZN). What is the management fee for Franklin Genomic Advancements ETF? Franklin Genomic Advancements ETF's management fee is 0.50% and has no other recorded expenses or fee waivers. The net expense ratio for HELX is 0.50%. How do I buy shares of Franklin Genomic Advancements ETF? Shares of HELX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (BATS:HELX) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersNew Trump BombshellThe Freeport SocietyMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Franklin Genomic Advancements ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.